Stocks · Healthcare · Medical - Instruments & Supplies
DENTSPLY SIRONA Inc. XRAY
$8.67 -0.80% Close, Oct 2, 2026 · NASDAQ · Market cap $1.74B
Weak trend
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 11.7% from -28.2% a year earlier.
- Net debt is 12.1× EBITDA, a high level of leverage.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 28%
- FCF growth (TTM, YoY)Bottom 44%
- Revenue growth, 3-year CAGRBottom 19%
- Revenue growth accelerationTop 42%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 14%
- Gross marginBottom 33%
- Operating marginTop 23%
- Accruals (lower is better)Top 19%
- Net debt / EBITDA (lower is better)Bottom 5%
- Interest coverTop 26%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 23%
- Free-cash-flow yieldTop 10%
- EBITDA / enterprise valueTop 25%
- Sales / enterprise valueTop 10%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 28%
- 6-month returnBottom 20%
- 1-year return vs S&P 500Bottom 20%
- Distance from 52-week highBottom 39%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 44%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyBottom 6%
- Upside to consensus price targetBottom 46%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 37%
- Maximum drawdown, 3 yearsBottom 39%
- Beta vs S&P 500 (lower is better)Top 26%
- Net debt / EBITDA (lower is better)Bottom 5%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -1.0% | -0.8% | ↑ |
| Gross margin | 51.7% | 49.5% | ↓ |
| Operating margin | -28.2% | 11.7% | ↑ |
| FCF margin | 3.8% | 3.9% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -0.8% | -1.0% | ↑ | Bottom 28% |
| Gross margin | 49.5% | 51.7% | ↓ | Bottom 33% |
| Operating margin | 11.7% | -28.2% | ↑ | Top 23% |
| Net margin | -15.0% | -25.9% | ↑ | — |
| Free-cash-flow margin | 3.9% | 3.8% | ↑ | — |
| Return on invested capital | 10.0% | — | Top 14% | |
| Revenue growth, 3-year CAGR | -2.1% | — | Bottom 19% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -16.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -3.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 12.05×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 4.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 5.53%
- Net buyback yield (TTM)
- 0.69%
- Shareholder yield
- 6.22%
- Share count change, 1 year
- +0.6%
- Share count change, 3-year CAGR
- -2.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +6.1%
- Average 2-day reaction, last 8
- -5.0%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $13.40
- Target vs current price
- +54.6%
- Analysts with a rating
- 32
- Share rating Buy or Strong Buy
- 38%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +49.4% | -4.4% | -17.2% | -18.1% | — |
| May 5, 2026 | -3.6% | +1.5% | -2.6% | -12.2% | +22.7% |
| Feb 26, 2026 | -3.6% | -0.7% | +5.0% | -8.8% | -22.4% |
| Nov 6, 2025 | -17.8% | -12.7% | -14.1% | -10.7% | -4.9% |
| Aug 7, 2025 | +4.0% | -3.3% | +1.2% | +4.8% | -8.0% |
| May 8, 2025 | +48.3% | +16.3% | +20.2% | +16.2% | +4.6% |
| Feb 27, 2025 | -44.7% | -8.8% | -14.1% | -17.1% | -15.7% |
| Nov 7, 2024 | +4.2% | -28.0% | -27.6% | -19.5% | -19.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.52 | $0.35 | +49.4% | $898.0M |
| May 5, 2026 | $0.27 | $0.28 | -3.6% | $880.0M |
| Feb 26, 2026 | $0.27 | $0.28 | -3.6% | $961.0M |
| Nov 6, 2025 | $0.37 | $0.45 | -17.8% | $904.0M |
| Aug 7, 2025 | $0.52 | $0.50 | +4.0% | $936.0M |
| May 8, 2025 | $0.43 | $0.29 | +48.3% | $879.0M |
| Feb 27, 2025 | $0.26 | $0.47 | -44.7% | $905.0M |
| Nov 7, 2024 | $0.50 | $0.48 | +4.2% | $951.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 5.7× | — | — | — |
| EV / EBITDA | 22.2× | — | — | Top 25% |
| EV / Sales | 1.05× | — | — | Top 10% |
| Free-cash-flow yield | 8.23% | — | — | Top 10% |
| Earnings yield | -31.60% | — | — | Bottom 23% |
P/E over the past five years
Range 17.5× – 37.1× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.3%
- 200-day average slope (20 days)
- -1.0%
- Distance from 50-day average
- -22.1%
- Distance from 200-day average
- -25.3%
- RSI (14)
- 27.5
- Relative volume
- 1.19×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 48.8%
- Volatility vs own 5-year history
- 85th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.67
- Correlation with S&P 500
- 0.22
- Current drawdown from 1-year high
- -40.9%
- Maximum drawdown, 3 years
- -76.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| May 10, 2021 | Oct 2, 2026 | -87.5% | 1356 days | Not yet recovered |
| Jan 12, 2021 | Feb 18, 2021 | -13.3% | 25 days | 9 days (Mar 3, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.74B
- EPS, diluted (TTM)
- -$2.74
- Revenue (TTM)
- $3.64B
- Dividend yield
- 1.85%
- 52-week range
- $8.59 – $14.76
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $4.23B | $3.92B | $3.96B | $3.79B | $3.68B |
| Gross profit | $2.35B | $2.13B | $2.09B | $1.96B | $1.84B |
| Operating income | $608.0M | -$937.0M | -$85.0M | -$879.0M | $252.0M |
| Net income | $411.0M | -$950.0M | -$132.0M | -$910.0M | -$598.0M |
| EPS (diluted) | $1.87 | -$4.41 | -$0.62 | -$4.48 | -$3.00 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $951.0M | $905.0M | $879.0M | $936.0M | $904.0M | $961.0M | $880.0M | $898.0M |
| Net income | -$494.0M | -$430.0M | $20.0M | -$45.0M | -$427.0M | -$146.0M | -$10.0M | $37.0M |
| EPS (diluted) | -$2.46 | -$2.16 | $0.10 | -$0.23 | -$2.14 | -$0.73 | -$0.05 | $0.18 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $657.0M | $517.0M | $377.0M | $461.0M | $235.0M |
| Capital expenditure | -$142.0M | -$149.0M | -$149.0M | -$180.0M | -$131.0M |
| Free cash flow | $515.0M | $368.0M | $228.0M | $281.0M | $104.0M |
| Dividends paid | -$92.0M | -$104.0M | -$116.0M | -$126.0M | -$128.0M |
| Net share buybacks | -$200.0M | -$150.0M | -$300.0M | -$250.0M | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $239.0M
- Total assets
- $5.20B
- Total liabilities
- $3.85B
- Total debt
- $2.31B
- Net debt
- $2.07B
- Shareholders’ equity
- $1.35B
As of Jun 30, 2026 (filed Aug 6, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Dec 26, 2025 | $0.16 | Jan 9, 2026 |
| Sep 26, 2025 | $0.16 | Oct 10, 2025 |
| Jun 27, 2025 | $0.16 | Jul 11, 2025 |
| Mar 28, 2025 | $0.16 | Apr 11, 2025 |
| Dec 27, 2024 | $0.16 | Jan 10, 2025 |
| Sep 27, 2024 | $0.16 | Oct 11, 2024 |
| Jun 28, 2024 | $0.16 | Jul 12, 2024 |
| Mar 27, 2024 | $0.16 | Apr 12, 2024 |
Short interest
- Shares sold short
- 24,588,198
- Days to cover
- 6.91
- Change vs previous report
- +11.3%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jul 18, 2006
- 2-for-1
- Feb 1, 2002
- 3-for-2
- Oct 30, 1997
- 2-for-1
- Aug 24, 1992
- 2-for-1